International Journal of Gynecological Cancer

Article	Citations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study	212
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma	138
Controversies in the management of mucinous ovarian tumors	96
Early-Stage Breast Cancer: A Detailed Examination Of Clinicopathological Features	95
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma	87
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer	83
Management of stage III and IVa uterine cancer	80
Importance of stress management in gynecological cancer	74
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer	74
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)	58
Clinical Significance Of Low Volume Lymph Node Metastasis In Early Stage Cervical Cancer: A Single Centre Case Series	57
Does Sentinel Node Know The Cancer Origin? Comparing Sentinel Lymph Nodes Localization In Endometrial And Cervical Cancer	57
Perioperative Outcomes Of Heated Intraperitoneal Chemotherapy For Patients Enrolled In The Feasibility Phase Of A Randomized Controlled Trial: Laparoscopic Cytoreduction After Neoadjuvant Chemotherapy	54
PROGNOSTIC FACTORS BASED ON THE MOLECULAR CLASSIFICATION OF ENDOMETRIAL CANCER: SINGLE INSTITUTION STUDY	51
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism	49
Evaluating The Implementation And Outcomes Of The Tumor-First Testing Strategy For BRCA1/2 Pathogenic Variants In Ovarian Cancer Patients: A Center-Wide Analysis	49
Surgical Release Of The Pudendal Nerve By Robotic Approach In 10 Steps	47
Trop-2 Expression In Cervical Carcinoma (CX) - A Possible Target For The Antibody Drug Conjugate Sacituzumab	47
Prognostic Factors In Adult Granulosa Cell Tumours Of The Ovary And Long Term Follow-Up. (The Norwegian Radium Hospital Experience 1971-2024)	38
Comparative Outcomes Of Excision And Active Surveillance For Cervical Intraepithelial Neoplasia 2 In Women Under 35	36
The “N-PLUS/NOGGO-Ov53/ENGOT-Ov62-STUDY” To De-Escalate Chemotherapy In Ovarian Cancer: Comparing 3 Vs. 6 Cycles Of Platinum-Based Chemotherapy After Complete Tumor Resection Followed By Niraparib Mai	35
Surgical Treatment Of Advanced Ovarian Cancer: Experience From A Brazilian Cancer Center (Barretos Cancer Hospital) In 2023	35
Secondary Debulking Followed By Localised Radiotherapy In Patients With Oligometastatic Recurrent Ovarian Cancer – A Case Series Of Two International Cancer Centres	34
A Young Woman Presenting Virilization With Ovarian Mass: A Case Report Of Rare Disease - Ovarian Steroid Tumor	34
Excision Of Retroperitoneal Mass - Laparoscopic Management Of Iliac Artery Injury	34

Squamous Cell Carcinoma Arising In Mature Cystic Teratomas: A Case Series Review Of Presentation, Treatment, And Prognosis	34
Survival Prediction And Mortality Risk Stratification In Ovarian Cancer After NACT: PRGS Outperforms CRS Regression Scoring	34
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery	34
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins	33
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy	32
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization	30
The Role Of Second-Look Surgery In Recurrent Ovarian Cancer Based On The Type Of Relapse	30
Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis	30
Homologous Recombination Deficiency (HRD) In P53 Abnormal Endometrial Carcinoma	29
Overall survival after surgical staging by lymph node dissection versus sentinel lymph node biopsy in endometrial cancer: a national cancer database study	28
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies	28
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer	27
Correspondence on ‘Enhanced recovery after surgery in gynecologic oncology: time to address barriers to implementation in low- and middle-income countries’ by Nelson et al	27
Cervical cancer in pregnancy at various gestational ages	27
Inguinofemoral lymphadenectomy technique in 10 steps	27
Surgical technique and surgeon volume: the pursuit of data-driven outcomes	26
Patient-initiated follow-up in low-risk endometrial cancer after surgery: a systematic review	25
Laparoscopic approach to paravaginal low-grade sarcoma	25
SPLEEN PRESERVING EXTENSIVE CYTOREDUCTIVE SURGERY	24
Impact Of Surgery On Survival Outcomes In Locally Advanced Cervical Cancer Patients With Partial Response After Primary Chemoradiotherapy	24
Impact Of Preoperative Conization On The Prognosis Of Cervical Cancer Patients Undergoing Open Abdominal Radical Hysterectomy	23
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy	22
Histological Findings After Completion Hysterectomy And Clinical Outcome Following Conservative Treatment Of Endometrial Carcinoma	22
Impact Of Ascites And Peritoneal Metastatic Lesion Volumes, Measured By Newly Developed Deep Learning-Based Algorithm, In Advanced Epithelial Ovarian Cancer	22
The Prognostic And Predictive Value Of Cardiophrenic Lymph Nodes In Patients Receiving Hyperthermic Intraperitoneal Chemotherapy For Ovarian Cancer In The OVHIPEC-1 Trial	21
Does The Origin Of Ovarian Cancer Influence Outcomes?	21
The Silva Pattern-Based Classification And Oncological Outcomes In Women Undergoing Fertility-Sparing Surgery For Early-Stage Cervical Cancer	21
A Multivariable Prognostic Analysis For Survival Outcomes In Women With Epithelial Ovarian Cancer - A North Indian Single Centre Study	21
Prospective Multicentre Evaluation Of Secondary Cytoreductive Surgery In The Era Of PARP-Inhibitors (CONCEPT) In Relapsed Epithelial Ovarian Cancer	20
The Role Of Prehabilitation In ERAS For Gynecologic Oncology In Germany	20
Advanced Techniques In Pelvic Exenteration For Cervical Cancer: A Case-Based Surgical Guide	20
To Compare The Colposcopic Findings By International Federation Of Colposcopy And Cervical Pathology (IFCPC ) Nomenclature And Swede Score For Assessment Of High Grade Cervical Lesions	20
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’	18
ROCC/GOG-3043: a randomized controlled trial of robotic versus open surgery for early-stage cervical cancer	18
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry	18
Correspondence on “Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysis” by Zhu and colleagues	18
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets	18
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)	18
Growing teratoma syndrome	18
Vulvar cancer resection with V–Y advancement flap reconstruction	17
Well-differentiated papillary mesothelial tumor of the peritoneum	17
PARSGO and UM6SS: spearheading excellence in gynecological oncology in Morocco	17
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report	17
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation	17
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research a	16
Hepatic hilum cytoreductive surgery for ovarian cancer relapse	16
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study	16
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024	16
Performance of molecular classification in predicting oncologic outcomes of fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer	16
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation	16

Use of social media for academic and professional purposes by gynecologic oncologists	16
Utilization of artificial intelligence to mitigate health inequalities in gynecological cancer care	16
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico	16
Evaluating the use of machine learning in endometrial cancer: a systematic review	16
Preoperative PET Scan Is Associated With Lower Rates Of Adjuvant Treatment In Surgically Treated Cervical Cancer Patients: A 4C Working Group Study	15
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer	15
Safety and management of niraparib monotherapy in ovarian cancer clinical trials	15
Use of quadratus lumborum block in gynecologic procedures	15
Survival After Incidental Cervical Cancer Diagnosis Following Simple Hysterectomy Compared To Planned Oncological Management In Tumors ≤2 Cm	15
Topographic Distribution Of Histologically Confirmed Pelvic And Aortic Lymph Node Metastasis In Stage IIIC1r Locally Advanced Cervical Cancer: A Spain-GOG Retrospective Study.	15
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades	15
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer	15
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer	15
Comparative Efficacy Analysis Between Adjuvant Vaginal Cuff Brachytherapy And Pelvic External Beam Radiation Treatment For Women With FIGO Stage I Uterine Endometrioid Carcinoma With Pathologic Negati	15
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer. A practical tool from the GINECO group for quick and easy management.	15
Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis	15
Evaluating Surgical Efficiency In Robotic-Assisted Hysterectomies For Endometrial Cancer And Benign Gynecologic Conditions	14
Impact Of Patient Characteristics On Primary Treatment Approach; A Population Based Study Regarding Incidence, Management And Outcome Of Endometrial Cancer Patients In The Netherlands Over 1995-2022	14
The Role Of Completion Surgery After Menopause In Women With Borderline Ovarian Tumors Treated With Fertility Sparing Surgery - A Multicenter Retrospective Cohort Study	14
Obesity In Endometrial Cancer - A Patient Treated With Curative Radiotherapy Using A Custom-Made 3D-Printed Applicator	14
MANAGEMENT OF A WOMAN WITH CERVICAL MELANOMA: A CASE REPORT AND LITERATURE REVIEW	14
Solitary Splenic Metastasis In Endometrial Cancer - A Systematic Review And Case Presentation	14
Technical And Organizational Solutions For Research Endometrial Cancer Data Collection: The Ambispective, Multicentric ENDOCancer-DATA	14
Comparison Of VNOTES And Laparoscopic Surgery In Patients With Ascites	14
Glyoxalase 1: A Promising Biomarker And Target For Cervical Cancer Treatment	13
Long Term Outcomes In Patients Treated By Extensive Bowel Resection Due To Advanced Ovarian Cancer	13
Improving Postoperative Outcomes By Implementing A Gynaecological Oncology-Specific ERAS Pathway In A UK Gynaecological Cancer Centre.	13
The Impact Of BRCA Status On The Efficacy Of Paclitaxel Monotherapy In Recurrent Ovarian Cancer	13
Primary Ovarian Malignant Melanoma: A Case Report	13
Evaluation Of The MIDKINE Cytokine In Serum, Tumour Tissues And Lymph Nodes Of Patients With Endometrial Cancer	13
The Role Of Vaginal Microbiota And HPV DNA Methylation In Cervical Lesion Progression	13
Minimally Invasive Surgery In Early-Stage Ovarian Cancer: Recurrence Analysis	13
Impact Of The COVID-19 Pandemic On Ovarian Cancer Diagnosis, Treatment, And Outcomes: A Systematic Review And Meta-Analysis	13
Exceptional Survival And Carcinomatous Recurrence In Mixed Papillary Adenocarcinoma Of The Fallopian Tube: A Clinical Case Report	13
Treatment Strategies In Advanced Ovarian Cancer: Primary Cytoreductive Surgery And Adjuvant Chemotherapy Versus Neoadjuvant Chemotherapy And Interval Cytoreduction - A Single-Center Retrospective Obse	12
Squamous Cell Carcinoma Arising From A Mature Cystic Teratoma: A Rare Case	12
Serous-Borderline Ovarian Tumors With Micropapillary Pattern Variants With Microinvasion Mimicking Advanced Stage Ovarian Carcinoma : A Rare Case Report	12
The Impact Of Hyperthermia On Cisplatin Cytotoxicity In Ovarian Cancer Cells	12
GENE EXPRESSION BASED STUDY TO IDENTIFY POOR PROGNOSTIC INDICATORS IN CARCINOMA CERVIX	12
Exploring The Correlation Of Early Sexual Debut On Cervical HPV Infection In LMICs: Insights Through The Lens Of Sustainable Development Goals	12
Parental Knowledge And Health Beliefs Of HPV Vaccination In Kuwait: A Cross-Sectional Descriptive Survey	12
12-Year Overall Survival And Prognostic Factors In Patients With FIGO Stage IA-IVA Vulvar Cancer Undergoing Surgery ± Adjuvant Radiation Therapy. Results From A Single Eastern European Center.	12
Is It Time To Revise Cervical Cancer Screening Guidelines?	12
ANTERIOR EXENTERATION FOR MULTIFOCAL VAGINAL CARCINOMA	12
CDK7 Inhibition By THZ1 Triggers Pyroptosis And Enhances Immune Response In Ovarian Cancer	12
Assessing The Implications Of Sentinel Lymph Node Removal In Cervical Cancer: An Immunogenetic Perspective – A SENTICOL/GINECO Ancillary Study	12
Evaluation Of Clitoral Artery Doppler Parameters After Brachytherapy And Its Effects On Sexual Functions	12
CLINICAL CHARACTERISTICS AND PROGNOSIS OF CLEAR CELL OVARIAN CARCINOMA IN A HOSPITAL IN PERU	12
ARE ALL MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCERS CREATED EQUAL? A LARGE, RETROSPECTIVE, TERTIARY CENTER EXPERIENCE.	12
Ultrasound, macroscopic and histological features of endometrioid and clear cell ovarian cancer	11
Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare	11
Rising endometrial cancer rates and potential for screening	11
Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation	11
Some thoughts about surgery in ovarian cancer 2021	11
Peritoneal cancer index: laparoscopic evaluation of peritoneal carcinomatosis from gynecological origin	11
Medical treatment of patients with gynecologic cancer during the COVID-19 pandemic	11
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression	11
Urinary Complications Of Bricker Procedures In Oncogynecology: A Monocentric Retrospective Analysis Of 77 Cases Over 20 Years	11
Advanced metastatic G1 endometrioid endometrial carcinoma (no specific molecular profile group)	11
Advanced ovarian yolk sac tumor: upfront surgery or neoadjuvant chemotherapy followed by interval debulking?	11
Response to: Correspondence on 'Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer' by Zhang and Sun	11
Can the Tilburg Frailty Indicator predict post-operative quality of recovery in patients with gynecologic cancer? A prospective cohort study	11
Abnormal Uterine Bleeding As A Predictor Of Endometrial Hyperplasia And Cancer Pathology In Postmenopausal Tamoxifen Treated Breast Cancer Patients	11
Incidence And Impact Of Low Volume Lymph Node Metastasis In Apparent Early-Stage Ovarian Cancer – MICR-OVARY Study.	11
Pelvic chondrosarcoma presenting as an adnexal mass treated with pubic bone resection	11
Fertility-sparing treatment in early-stage cervical adenocarcinoma: assessing feasibility and limitations	11
Opioid and benzodiazepine use in gynecologic oncology patients	11
Correspondence on ‘Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer’ by Luzarraga Aznar et al	11
Purple bag syndrome: a visual clue for infection	11
Brenner'S Tumors: An Update	11
Oncological outcomes after laparotomic, laparoscopic, and robot-assisted laparoscopic staging for early high–intermediate or high- risk endometrial cancer	10
Are We Facing A Paradigm Shift In The Treatment Of Advanced Ovarian Cancer? Neoadjuvant Therapy Vs Primary Surgery	10
Correspondence on “Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods” by Navarro Santana et al	10
Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer	10
Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines	10
Therapeutic Resistance In Synchronous Endometrioid Carcinomas: A Case Report With A Pathogenic Germline Mutation In PMS2	10
Mirvetuximab soravtansine shines post-PARP inhibitor progression: promising insights from the PICCOLO trial	10
The tug of war: delivering safe gynecologic oncology treatment amid insecurity in Haiti	10
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer	10
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions	10

Role of lymphadenectomy in advanced ovarian cancer—a subgroup analysis of the patients excluded from the LION trial (the Charité cohort)	10
Risk factors for lymphedema and method of assessment in endometrial cancer: a prospective longitudinal multicenter study	10
Fertility-sparing approach for uterine smooth muscle tumors of uncertain malignant potential	10
Biomarkers for checkpoint inhibitor therapy in mucinous epithelial ovarian cancer	10
Clinical and pathological overview of endometrial endometrioid carcinoma	10
Exploring global barriers to optimal ovarian cancer care: thematic analysis	10
Low grade endometrioid endometrial cancer: complexities beyond p53abn	10
Journal Information	10
HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries	10
The application of metabolomics in ovarian cancer management: a systematic review	9
Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary	9
First workshop on cervix cancer surgery in Latin America: a hands-on experience from Lima, Perú	9
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy	9
Huge cystic renal cell carcinoma misdiagnosed as ovarian cancer	9
Uterine transposition for fertility and ovarian function preservation after radiotherapy	9
Correspondence on ‘Cardiophrenic and costophrenic lymphadenectomy in advanced ovarian cancer by prediaphragmatic subxiphoid approach: PS technique’ by Stanciu	9
Analysis of the global burden of ovarian cancer in adolescents	9
Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer ≤2 cm (LESSER)	9
Correspondence on ‘Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis’ by Vieira-Serna et al	9
Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer	9
Cost impact analysis of enhanced recovery after minimally invasive gynecologic oncology surgery	9
European multidisciplinary tumor boards support cross-border networking and increase treatment options for patients with rare gynecological tumors	9
Horseshoe kidney	9
Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program	9
Copy number variations in endometrial cancer: from biological significance to clinical utility	9
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation	8
Correction: Oncologic outcomes of uterine preservation for pre-menopausal patients with stage II epithelial ovarian carcinoma	8
Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium	8
Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva	8
VIOLA Project: Preventing Vulvo-Vaginal Alterations Post-Treatment In Gynecological Cancer Patients	8
The Use Of Ambient Metabolomics To Enhance The Diagnosis And Treatment Of Cervical Precancer And Cancer	8
HPV Self-Collected Cervical Cancer Screening And Women Participation In Areas With Limited Access To Health Services In Colombia	8
Terminal T-Cell Exhaustion Is A Prognostic Biomarker Of Clinical Outcome In Homologous Recombination Deficient Ovarian Cancer	8
Randomized Study Evaluating Optimal Dose, Efficacy And Safety Of E7386 + Lenvatinib Versus Treatment Of Physicians’ Choice In Advanced/Recurrent Endometrial Carcinoma Previously Treated With Anti-PD-(	8
Prospective Assessment Of The Association Between Perioperative Fluid Balance And Postoperative Complications After Surgery For Advanced Ovarian Cancer; Ancillary Data From A Randomised Controlled Tri	8
Real-World Demographics And Survival Outcomes Of Patients In England With Advanced Or Recurrent Endometrial Cancer By Mismatch Repair Status	8
Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study	8
Serous endometrial intra-epithelial carcinoma: an observational study	8
Accuracy And Performance Of Different Tracers In Sentinel Lymph Node Biopsy In Endometrial Cancer: A Single-Institution Retrospective Study	8
Radical Colpohysterectomy: A Step-By-Step Video Guide Of A Single-Patient Case	8
Anterior Exenteration And Bricker Urinary Diversion For Cervical Cancer Recurrence	8
Adenocarcinoma Of Anogenital Mammary-Like Glands – A Rare Primary Vulvar Tumor	8
Characterization Of The Immuno-Oncological Transcriptomic Landscape Of Uterine Smooth Muscle Tumors Of Uncertain Malignancy Potential (STUMP) According To Clinical Outcome	8
Gracilis Flap For Vulvar Reconstruction In 10 Steps	8
Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer – Update 2023*'	8
Validation of the 2021 FIGO staging schema for advanced vulvar cancer	8
Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer	8
Sentinel Lymph Node Mapping With Indocyanine Green In Endometrial Cancer	8
Unscheduled Bleeding In Postmenopausal Women On Hormone Replacement Therapy: A Single-Centre Analysis Of Endometrial Cancer Risk	8
Patients With Endometrial Cancer: Exploring Comorbidities And Quality Of Life – First Results Of An International Survey (NOGGO, ENGOT, GCIG - IMPROVE/EXPRESSION XI)	8
Uterine Carcinosarcoma (UCS): Literature Review And Survival Analysis From A Retrospective Cohort Study	8
Malignant Struma Ovarii: A Series Case Report	8
Complete Resection After Interval Cytoreductive Surgery For Advanced Ovarian Cancer Subjected To Neoadjuvant Chemotherapy: A Systematic Review And Meta-Analysis Of Diagnostic Test Accuracy	8
Lymph Node And Distant Metastases In Staging And Re-Staging Of Uterine Cervical Cancer: Precise Diagnosis And Mapping Using FDG-PET/CT	7
Beyond Trauma: A Survivor’s Story Of Cervical Carcinosarcoma	7
Does Size Matter? The Prognostic Role Of Lymph Node Metastasis Dimension In Endometrial Cancer Molecular Classification. A Multicentre, Retrospective Study	7
Principles Of Laparoscopic Nerve Sparing Technique In Gynecological Surgery, Evaluation Of 290 Procedures	7
Obstetric Outcome Following Conservative Treatment Of Endometrial Carcinoma	7
Urine High Risk Human Papillomavirus Testing As An Alternative Cervical Screening Strategy: The ACES Studies	7
The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvant chemotherapy	7
Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: an individual patient level meta-analysis	7
Controversies in the Management of Mesonephric and Mesonephric-Like Adenocarcinomas of the Female Genital Tract	7
Comparison Of Microsatellite Instability Detection By Immunohistochemistry And Molecular Technique In Endometrial Cancer	7
Ovarian Cancer And Severe COVID-19 Outcomes: A Matched Case-Control Study	7
The Immune-Silenced Dialogue In Endometrial Cancer Tumor Microenvironment Escape: Could The Volume Be Tuned Up By The Fetal-Maternal Immune Tolerance Cross-Talk?	7
Morbidities After Completion Surgery In Patients Treated For Locally Advanced Cervical Adenocarcinoma	7
The Association Between Postmenopausal Spontaneous Pyometra And Gynecological Cancer – The Experience Of A Tertiary Medical Center	7
Introducing The Comprehensive Complication Index (CCI) To Gynecologic Oncology	7
Beyond The Surface: The Impact Of Mucosal Bowel Invasion On Ovarian Cancer Staging	7
Transumbilical Single-Port Laparoscopic Para-Aortic Lymphadenectomy To The Left Renal Vein	7
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study	7
PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy	7
Neuroendocrine cervical carcinomas: genomic insights, controversies in treatment strategies, and future directions: a NeCTuR study	7
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) WITH A CLOSED CO2 RECIRCULATION DEVICE IN PERITONEAL CARCINOMATOSIS FROM ADVANCED EPITHELIAL OVARIAN/TUBAL CANCER AFTER INTERVAL DEBULKING SURGERY (ID	7
Monophasic Synovial Sarcoma Of The Vulva: A Case Report And Literature Review	7
Pelvic Exenteration: An Ultimate Option In Advanced Gynecologic Malignancies: A Single Center Experience	7
Predictive Value Of MRI Findings For Treatment Outcomes In Early Endometrial Cancer Patients Undergoing Fertility-Sparing Treatment	7
ENDOESTRO-Score: Where Is The Dark Side? Evaluation Of Estrogen Receptor Expression Cut-Off In Endometrial Cancer Molecular Classification, A Retrospective Study	7
Obstetric And Oncology Outcomes Following Fertility-Sparing Surgery In Non-Epithelial Ovarian Cancer, Epithelial Ovarian Cancer And Borderline Ovarian Tumors: A Systematic Review And Meta-Analysis	7
Laparoscopic Transplantation Of Cryopreserved Ovarian Tissue With Autologous Platelet-Rich Plasma: A Way To Improve Fertility?	7
Men's role in women's health: Engaging male partners in cervical cancer prevention efforts in low-to-middle-income countries	7
Correspondence on “Oncologic outcomes based on lymphovascular space invasion in node- negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study” by D	7
Survival Analysis And Comparison Between Routine And Selective Lymphadenectomy During Optimally Debulked Interval Cytoreductive Surgery In Women With Advanced Stage Carcinoma Ovary Post Neoadjuvant Ch	7
Vulvar Cancer: Clinical Characteristics Of Patients In The Kasserine Region	7
Locally advanced vulvar carcinoma diagnosed during cervical cancer screening	7
Tunisian Women’s Perception And Knowledge Of Cervical Cancer Screening: Are We Aware Yet?	7
Relationship Between Amino Acid Transporters And Endometrial Cancer Subtypes	6
Prevalence Among Human Papillomavirus Genotypes In Endocervical Samples From Asymptomatic Women In Cajamarca, Peru	6
Unmet Information Needs Of Vaginal Rehabilitation After Pelvic Radiotherapy: To Cure Or To Care?	6
Inflammation And Nutrition-Based Scores For Prognosis In Lenvatinib And Pembrolizumab Therapy For Recurrent Endometrial Cancer	6
Sonographically Atypical Ovarian Fibroma In Pregnancy: A Case Report And Review Of The Adnexal Malignancy Risk Assessment During Gestation	6
Assessment Of Sentinel Lymph Node Biopsy Compared To Lymphadenectomy For Endometrial Cancer Staging: Experience From An ESGO Certified Center	6
Management Of Patients With Endometrial Hyperplasia: An Experience In A Tertiary Centre Over A 12-Month Period	6
ICG Mapping Of Sentinel Lymph Nodes In Patients With Early Stages Of Endometrial And Cervical Cancer Depending On Body Mass Index	6
Single-Port Robotic Surgery Feasibility In Gynecologic Oncology: Referral Center Experience	6